Dipeptidylpeptidase IV (DPIV) and alanyl-aminopeptidases (AAPs) as a new target complex for treatment of autoimmune and inflammatory diseases-proof of concept in a mouse model of colitis.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples